Comprehensive efficacy of ipragliflozin on various conditioned type 2 diabetes compared with dipeptidyl peptidase-4 inhibitors and with both agents, based on a real-world multicenter trial
基于一项真实世界多中心试验,评估了伊格列净对各种条件性2型糖尿病患者的综合疗效,并与二肽基肽酶-4抑制剂以及两种药物联合使用进行了比较。
期刊:Diabetology International
影响因子:1.2
doi:10.1007/s13340-021-00492-8
Sawano, Fumio; Kamei, Nozomu; Miyahara, Mitsue; Kobuke, Kyoko; Nakanishi, Shuhei; Nagano, Chihiro; Nojima, Hideki; Maeda, Shusaku; Watanabe, Hiroshi; Kishimoto, Rui; Yamashita, Mami; Hamaoka, Aya; Mukai, Kana; Tsuboi, Tomoko; Mochizuki, Hisayoshi; Nakashima, Reiko; Sakashita, Yu; Morishita, Hisaaki; Kitamura, Tadahiro